Please use this identifier to cite or link to this item:
http://hdl.handle.net/11452/27089
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.date.accessioned | 2022-06-13T08:07:55Z | - |
dc.date.available | 2022-06-13T08:07:55Z | - |
dc.date.issued | 2015-11 | - |
dc.identifier.citation | Sarandöl, A. vd. (2015). "First-episode psychosis is associated with oxidative stress: Effects of short-term antipsychotic treatment". Psychiatry and Clinical Neurosciences, 69(11), 699-707. | en_US |
dc.identifier.issn | 1323-1316 | - |
dc.identifier.uri | https://doi.org/10.1111/pcn.12333 | - |
dc.identifier.uri | https://onlinelibrary.wiley.com/doi/10.1111/pcn.12333 | - |
dc.identifier.uri | http://hdl.handle.net/11452/27089 | - |
dc.description.abstract | AimsIn the present study, our aim was to investigate the oxidative-antioxidative systems in unmedicated first-episode psychosis (FEP) patients at the beginning and after short-term treatment. MethodsThis study consisted of 29 patients who experienced an FEP and 25 control subjects. In order to investigate the oxidative status, we determined plasma malondialdehyde (MDA) levels, oxidizability of red blood cells, oxidation and oxidizability of apolipoprotein B-containing lipoproteins (apo B-basal MDA and apo B-MDA). In order to evaluate the antioxidative defense, we measured serum total antioxidative capacity, uric acid, albumin, total bilirubin and vitamin E levels and serum paraoxonase/arylesterase, whole blood glutathione peroxidase (GPx) and red blood cell superoxide dismutase activities before and after 6 weeks of treatment in patients with FEP. ResultsPlasma MDA and apo B-basal MDA levels and red blood cell superoxide dismutase activity were significantly higher and serum arylesterase and whole blood-GPx activities were lower in the FEP group than those of the healthy control group. There were not any significant changes in the oxidative and antioxidative system parameters (except increased vitamin E levels) after treatment. ConclusionsThe results of this study suggest that FEP is accompanied by oxidative stress. However, further studies are needed to clarify the role of oxidative stress in the physiopathologic mechanisms of FEP, so that oxidative and antioxidative system parameters can be used in the management of these patients. In accordance with psychiatric evaluation, for a better management, patients with FEP may require a multidisciplinary approach, including oxidative and antioxidative system parameters. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Wiley | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Affective disorders | en_US |
dc.subject | Antioxidant | en_US |
dc.subject | First-episode psychosis | en_US |
dc.subject | Oxidative stress | en_US |
dc.subject | Schizophrenia | en_US |
dc.subject | Low-density-lipoprotein | en_US |
dc.subject | Drug-naive patients | en_US |
dc.subject | Antioxidant defense | en_US |
dc.subject | Lipid peroxide | en_US |
dc.subject | Sschizophrenia | en_US |
dc.subject | Plasma | en_US |
dc.subject | Onset | en_US |
dc.subject | Susceptibility | en_US |
dc.subject | Disease | en_US |
dc.subject | Neurosciences & neurology | en_US |
dc.subject | Psychiatry | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Antipsychotic agents | en_US |
dc.subject.mesh | Apolipoprotein B-100 | en_US |
dc.subject.mesh | Aryldialkylphosphatase | en_US |
dc.subject.mesh | Bilirubin | en_US |
dc.subject.mesh | Carboxylic ester hydrolases | en_US |
dc.subject.mesh | Case-control studies | en_US |
dc.subject.mesh | Erythrocytes | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Glutathione peroxidase | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Malondialdehyde | en_US |
dc.subject.mesh | Oxidation-reduction | en_US |
dc.subject.mesh | Oxidative stress | en_US |
dc.subject.mesh | Psychotic disorders | en_US |
dc.subject.mesh | Serum albumin | en_US |
dc.subject.mesh | Superoxide dismutase | en_US |
dc.subject.mesh | Uric acid | en_US |
dc.subject.mesh | Vitamin E | en_US |
dc.subject.mesh | Young adult | en_US |
dc.title | First-episode psychosis is associated with oxidative stress: Effects of short-term antipsychotic treatment | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000363891900005 | tr_TR |
dc.identifier.scopus | 2-s2.0-84945458763 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Psikiyatri Anabilim Dalı. | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Klinik Biyokimya Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0002-2593-7196 | tr_TR |
dc.identifier.startpage | 699 | tr_TR |
dc.identifier.endpage | 707 | tr_TR |
dc.identifier.volume | 69 | tr_TR |
dc.identifier.issue | 11 | tr_TR |
dc.relation.journal | Psychiatry and Clinical Neurosciences | en_US |
dc.contributor.buuauthor | Sarandöl, Aslı | - |
dc.contributor.buuauthor | Sarandöl, Emre | - |
dc.contributor.buuauthor | Açıkgöz, Hacer Ebru | - |
dc.contributor.buuauthor | Eker, Salih Saygın | - |
dc.contributor.buuauthor | Akkaya, Cengiz | - |
dc.contributor.buuauthor | Dirican, Melahat | - |
dc.contributor.researcherid | ABE-1716-2020 | tr_TR |
dc.contributor.researcherid | Q-9477-2019 | tr_TR |
dc.identifier.pubmed | 26172069 | tr_TR |
dc.subject.wos | Clinical neurology | en_US |
dc.subject.wos | Neurosciences | en_US |
dc.subject.wos | Psychiatry | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q3 | en_US |
dc.contributor.scopusid | 14020405100 | tr_TR |
dc.contributor.scopusid | 55943324800 | tr_TR |
dc.contributor.scopusid | 56800707200 | tr_TR |
dc.contributor.scopusid | 14019347700 | tr_TR |
dc.contributor.scopusid | 14061855100 | tr_TR |
dc.contributor.scopusid | 6601919847 | tr_TR |
dc.subject.scopus | Oxidative Stress; Acetylcysteine; Bipolar Disorder | en_US |
dc.subject.emtree | Albumin | en_US |
dc.subject.emtree | Alpha tocopherol | en_US |
dc.subject.emtree | Apolipoprotein B | en_US |
dc.subject.emtree | Aryldialkylphosphatase | en_US |
dc.subject.emtree | Arylesterase | en_US |
dc.subject.emtree | Bilirubin | en_US |
dc.subject.emtree | Glutathione peroxidase | en_US |
dc.subject.emtree | Malonaldehyde | en_US |
dc.subject.emtree | Neuroleptic agent | en_US |
dc.subject.emtree | Superoxide dismutase | en_US |
dc.subject.emtree | Uric acid | en_US |
dc.subject.emtree | ALB protein, human | en_US |
dc.subject.emtree | Alpha tocopherol | en_US |
dc.subject.emtree | APOB protein, human | en_US |
dc.subject.emtree | Apolipoprotein B100 | en_US |
dc.subject.emtree | Aryldialkylphosphatase | en_US |
dc.subject.emtree | Arylesterase | en_US |
dc.subject.emtree | Bilirubin | en_US |
dc.subject.emtree | Carboxylesterase | en_US |
dc.subject.emtree | Glutathione peroxidase | en_US |
dc.subject.emtree | Malonaldehyde | en_US |
dc.subject.emtree | Neuroleptic agent | en_US |
dc.subject.emtree | Serum albumin | en_US |
dc.subject.emtree | Superoxide dismutase | en_US |
dc.subject.emtree | Uric acid | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Clinical article | en_US |
dc.subject.emtree | Clinical evaluation | en_US |
dc.subject.emtree | Controlled study | en_US |
dc.subject.emtree | Enzyme activity | en_US |
dc.subject.emtree | Enzyme blood level | en_US |
dc.subject.emtree | Erythrocyte | en_US |
dc.subject.emtree | Female | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Oxidation | en_US |
dc.subject.emtree | Oxidative stress | en_US |
dc.subject.emtree | Pathophysiology | en_US |
dc.subject.emtree | Patient care | en_US |
dc.subject.emtree | Protein blood level | en_US |
dc.subject.emtree | Psychosis | en_US |
dc.subject.emtree | Short course therapy | en_US |
dc.subject.emtree | Vitamin blood level | en_US |
dc.subject.emtree | Blood | en_US |
dc.subject.emtree | Case control study | en_US |
dc.subject.emtree | Drug effects | en_US |
dc.subject.emtree | Metabolism | en_US |
dc.subject.emtree | Oxidation reduction reaction | en_US |
dc.subject.emtree | Oxidative stress | en_US |
dc.subject.emtree | Psychotic disorders | en_US |
dc.subject.emtree | Young adult | en_US |
Appears in Collections: | Scopus Web of Science |
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.